A college student in Reading, Berkshire has died from meningitis, with two others currently receiving treatment for the same infection. The outbreak has renewed focus on recognizing the disease's warning signs and understanding vaccination options.
Meningitis causes inflammation of the membranes surrounding the brain and spinal cord. Early symptoms include high fever, severe headache, stiff neck, sensitivity to light, nausea, and vomiting. A characteristic rash may appear, starting as small red or pink spots that don't blanch when pressed. Confusion, drowsiness, and seizures can develop in severe cases. Symptoms can progress rapidly, sometimes within hours, making swift medical attention essential.
Bacterial meningitis poses the greatest mortality risk and requires immediate antibiotic treatment. Viral meningitis typically causes less severe illness, though recovery can take weeks. Fungal and parasitic forms exist but remain less common in developed nations.
Vaccination provides protection against several meningitis types. The meningococcal vaccine protects against Neisseria meningitidis, a major bacterial cause. The pneumococcal vaccine shields against Streptococcus pneumoniae. In the UK, meningitis B vaccine became part of the childhood immunization schedule in 2015. The meningitis ACWY vaccine covers additional meningococcal strains and is offered to teenagers and young adults, particularly those entering university where close living quarters increase transmission risk.
Close contacts of confirmed cases typically receive preventive antibiotics. Healthcare providers urge anyone experiencing sudden fever with headache and stiff neck to seek emergency medical care immediately. Delays in diagnosis and treatment correlate with worse outcomes and higher mortality rates. Public health officials continue monitoring the Reading cases and advising residents on symptoms requiring urgent hospital evaluation.